- MRTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Mirati Therapeutics (MRTX) 10-Q/A2018 Q1 Quarterly report (amended)
Filed: 20 Aug 18, 12:00am
Date: August 20, 2018 | /s/ Jamie A. Donadio | |
Jamie A. Donadio | ||
Senior Vice President and Chief Financial Officer | ||
(Principal Financial Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.